Safety and Efficacy of Rivaroxaban in Patients With Cardiac Implantable Electronic Devices: Observations From the ROCKET AF Trial

BACKGROUND: Although implantation of cardiac implantable electronic devices (CIEDs) in patients receiving warfarin is well studied, limited data are available on the use of oral factor Xa inhibitors in this setting. METHODS AND RESULTS: Using data from Rivaroxaban Once Daily Oral Direct Factor Xa In...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Am Heart Assoc
Autores principales: Leef, George C., Hellkamp, Anne S., Patel, Manesh R., Becker, Richard C., Berkowitz, Scott D., Breithardt, Günter, Halperin, Jonathan L., Hankey, Graeme J., Hacke, Werner, Nessel, Christopher C., Singer, Daniel E., Fox, Keith A.A., Mahaffey, Kenneth W., Piccini, Jonathan P.
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5669143/
https://ncbi.nlm.nih.gov/pubmed/28615214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.116.004663
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares